The correlation between dietary fat quality indices and lipid profile with Atherogenic index of plasma in obese and non-obese volunteers: a cross-sectional descriptive-analytic case-control study

Moussavi Javardi, Maryam Sadat; Madani, Zahra; Movahedi, Ariyo; Karandish, Majid; Abbasi, Behnood

doi:10.1186/s12944-020-01387-4

Lipids in Health and Disease

Table 2 The Comparison of fat quality intake in two groups of normal and overweight or obese

From: The correlation between dietary fat quality indices and lipid profile with Atherogenic index of plasma in obese and non-obese volunteers: a cross-sectional descriptive-analytic case-control study

Variable	Normal weight (n = 71)				Overweight/Obese (n = 86)				P-Value
Variable	Mean ± SD	Median	Mode	Range	Mean ± SD	Median	Mode	Range	P-Value
AI^a	228.19 ± 28.32	226.3	203.04	197.02–260.21	461.48 ± 52.81	456.93	469.12	408.08–519.01	0.012*
TI^a	471.15 ± 46.14	474.64	456.09	436.78–522.66	484.45 ± 50.63	474.64	465.96	431.96–537.84	0.841
hH^a	71.85 ± 3.78	69.21	70.43	66.86–75.64	49.94 ± 4.13	50.69	49.97	43.35–55.14	0.034*
CSI^a	30.40 ± 0.45	30.03	30.64	29.88–31.22	31.00 ± 0.93	31.10	30.94	30.07–32.33	0.824
Total fat	90.30 ± 35.51	89.11	74.07	55.09–126.98	95.52 ± 42.73	96.78	97.01	52.49–137.24	0.412
∑SFA	19.55 ± 8.01	20.03	18.93	11.04–27.68	22.01 ± 10.40	21.54	21.82	11.76–32.47	0.066
Loric acid (c12:0)	0.40 ± 0.27	0.39	0.43	0.12–0.68	0.41 ± 0.27	0.40	0.45	0.13–0.71	0.715
Myristic acid (14:0)	1.43 ± 0.87	1.32	1.50	0.57–2.30	1.56 ± 0.88	1.62	2.02	0.67–2.48	0.325
Palmitic acid (16:0)	8.43 ± 3.64	8.41	9.93	4.80–12.02	9.34 ± 4.67	9.35	8.28	4.72–14.01	0.875
Stearic acid (18:0)	4.00 ± 1.78	4.14	3.94	2.21–5.78	4.42 ± 2.41	4.52	4.78	2.01–6.71	0.062
∑MUFA	23.99 ± 11.38	24.41	22.86	12.04–35.18	21.97 ± 8.61	22.11	22.29	13.34–30.57	0.207
Oleic acid (18:1)	15.55 ± 8.43	15.98	14.07	7.33–19.42	13.38 ± 6.10	13.47	11.55	7.28–19.46	0.812
Palmitoleic acid (16:1)	0.79 ± 0.63	0.72	0.70	0.17–1.43	0.69 ± 0.43	0.68	0.93	0.24–1.15	0.209
∑PUFA	19.25 ± 12.20	21.22	15.03	7.20–30.03	22.45 ± 12.72	21.57	19.31	8.95–33.94	0.920
Linoleic acid (18:2n6)	1.22 ± 1.34	1.25	0.73	0.14–2.57	1.45 ± 1.24	1.59	1.08	0.20–2.69	0.267
C18.2.CLAs	0.41 ± 0.72	0.31	0.36	0.29–1.15	0.23 ± 0.32	0.28	0.21	0.09–0.58	0.144
Linolenic acid (18:3n6)	0.12 ± 0.14	0.09	0.13	0.03–0.30	0.17 ± 0.13	0.11	0.16	0.05–0.33	0.177
Linolenic acid (18:3n3)	0.41 ± 0.27	0.45	0.38	0.12–0.70	0.52 ± 0.27	0.49	0.56	0.24–0.79	0.565
Dihomo-linolenic acid (20:3n6)	0.34 ± 1.45	0.31	0.26	0.10–1.88	0.42 ± 1.23	0.45	0.37	0.08–1.79	0.129
Arachidonic acid (20:4n6)	0.11 ± 0.10	0.09	0.07	0.01–0.23	0.18 ± 0.08	0.19	0.16	0.08–0.29	0.212
Eicosapentaenoic acid (20:5n3) EPA	0.04 ± 0.05	0.03	0.02	0.01–0.11	0.03 ± 0.04	0.02	0.02	0.01–0.08	0.615
Docosahexaenoic acid (22:6n3) DHA	0.13 ± 0.12	0.11	0.05	0.01–0.26	0.12 ± 0.11	0.10	0.08	0.01–0.25	0.779
ω-6/ω-3 ratio	4.27 ± 0.29	4.25	4.50	3.98–4.59	4.60 ± 0.27	4.61	4.52	4.32–4.89	0.004**
Cholesterol	224.36 ± 112.73	228.65	201.12	110.14–332.38	250.89 ± 174.34	254.08	247.36	87.12–413.97	0.250
Total trans	4.39 ± 10.81	3.21	3.89	3.13–15.29	5.58 ± 10.27	3.98	4.27	3.51–10.09	0.481

^a Variables were compared using t independent test, rest of the variables were compared using Mann–Whitney U test. * Stands for P < 0.05. ** Stands for P < 0.01. Abbreviation: AI Atherogenicity index; TI Thrombogenicity index; H/H Σhypocholesterolemic/Σ Hypercholesterolemic ratio; CSI Cholesterol-Saturated Fat Index; ω-6/ω-3 Σ of Omega 6 series/Σ of Omega 3 series; SFAs saturated fatty acids; MUFAs monounsaturated fatty acids; PUFAs polyunsaturated fatty acids; ω6 omega 6 fatty acid (Linoleic acid); ω3 omega 3 fatty acid (Linolenic acid); P < 0.05 was considered to be significant

Back to article page

ISSN: 1476-511X

Contact us

General enquiries: journalsubmissions@springernature.com